Qianwen Cheng
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Macrophage migration inhibitory factor as a prognostic biomarker in multiple myeloma: clinical significance and in vitro effects.
Journal: Carcinogenesis
Published: March 01, 2025
Hematologists' awareness of venous thromboembolism in multiple myeloma: a national survey in China.
Journal: Annals of medicine
Published: November 20, 2023
Development of a nomogram prognostic model for early Grade ≥ 3 infection in newly diagnosed multiple myeloma based on immunoparesis.
Journal: International immunopharmacology
Published: September 03, 2023
CCL18 promotes migration and invasion of multiple myeloma cells and is associated with poor prognosis.
Journal: Carcinogenesis
Published: September 18, 2022
FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 09, 2021
Prognostic nomogram incorporating cytokines for overall survival in patients with newly diagnosed multiple myeloma.
Journal: International immunopharmacology
Published: March 10, 2021
Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models.
Journal: Frontiers in oncology
Published: December 09, 2020
Incidence and Mortality Trends and Risk Prediction Nomogram for Extranodal Diffuse Large B-Cell Lymphoma: An Analysis of the Surveillance, Epidemiology, and End Results Database.
Journal: Frontiers in oncology
Published: July 31, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026